Clinical trial
Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With…
NCT00207090 · R-Pharm, Industry · Completed
Key facts
| NCT number | NCT00207090 |
|---|---|
| Title | Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer |
| Official title | Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer |
| Lead sponsor | R-Pharm, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumors, Neoplasms |
| Intervention type | Drug |
| Interventions | ixabepilone, Rifampin |
| Enrollment | 19 |
| Start date | Sep 1, 2005 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Nov 2, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: